Search clinical trials for: Dapsone plus Tretinoin Gel

Total 127 results

Bausch Health Americas, Inc.

Completed

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Acne Vulgaris

United States
Allergan

Completed

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Acne Vulgaris

United States
Peking University People's Hospital
Ministry of Science and Technology of the People´s Republic of China

Not yet recruiting

Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL (RIF)

Acute Promyelocytic Leukaemia
Spear Pharmaceuticals

Completed

Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo

Acne

United States
Dermatrials Research
Johnson & Johnson

Completed

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

Acne

Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Acne Vulgaris | Acne

United States, Canada, Belize
Almirall, S.A.
Allergan

Completed

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Torrent Pharmaceuticals Limited
Catawba Research

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Coria Laboratories, Ltd.

Completed

Clinical Evaluation of the Photoallergy Potential of Atralin Gel

Healthy

United States
Almirall, S.A.
Allergan

Completed

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Almirall, S.A.
Allergan

Completed

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Memorial Sloan Kettering Cancer Center

Terminated

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma

Neuroblastoma

United States
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Coria Laboratories, Ltd.

Completed

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Rosacea

United States
Coria Laboratories, Ltd.

Completed

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Healthy

United States
Government Dental College and Research Institute...

Completed

Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis

Chronic Periodontitis

India
Allergan

Completed

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Rosacea

United States
Lisa E. Maier
Bausch Health Americas, Inc.

Terminated

Atralin Gel for the Treatment of Rosacea

Rosacea

United States
Vanderbilt University Medical Center

Terminated

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

Dermatitis Herpetiformis

United States
Zeichner, Joshua, M.D.

Unknown

A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Allergan

Completed

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Acne Vulgaris

United States
Allergan

Withdrawn

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Acne Vulgaris
Allergan

Completed

A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%

Acne Vulgaris
Seegpharm S.A.

Completed

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Kafrelsheikh University

Not yet recruiting

Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications

COVID
Government Dental College and Research Institute...

Completed

Alendronate Compared to Metformin in Chronic Periodontitis

Chronic Periodontitis
LEO Pharma

Completed

Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

Acne Vulgaris

France
John H. Stroger Hospital

Unknown

Dapsone Prurigo Study

Lichen Simples Chronicus and Prurigo

United States
Bausch Health Americas, Inc.

Completed

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Allergan

Withdrawn

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Acne Vulgaris
Actavis Mid-Atlantic LLC

Completed

Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo

MILD TO SEVERE ACNE VULGARIS

India
Kafrelsheikh University
Ministry of Health, Saudi Arabia; Foshan University Laboratory of Emerging... and other collaborators

Not yet recruiting

Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.

Post COVID-19 Anosmia (Loss of Smell)

China, Egypt, Saudi Arabia
Bausch Health Americas, Inc.

Completed

A Study of Different Use Regimens Using Two Acne Treatments

Acne Vulgaris

United States
Derm Research @ 888 Inc.
Stiefel, a GSK Company

Terminated

Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin

Acne Vulgaris

Canada
Allergan

Completed

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Acne Vulgaris

United States
Novan, Inc.

Completed

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Acne Vulgaris

United States
GlaxoSmithKline

Completed

W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers

Acne Vulgaris
Galderma R&D

Completed

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Photoaging

United States
University of Rome Tor Vergata

Completed

Class I Medical Device on Post-surgical Scars

Cicatrix | Keloid | Hypertrophic Scar | Post-Surgical Complication | Scar Itching

Italy
Assiut University

Not yet recruiting

DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Acne Vulgaris
Callender Center for Clinical Research
Society Hill Dermatology

Unknown

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Acne

United States
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Acne Vulgaris

United States
Massachusetts General Hospital
Medicis Pharmaceutical Corporation

Completed

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Rosacea

United States
Zeichner, Joshua, M.D.

Unknown

Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

Acne Vulgaris

United States
Allergan

Completed

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Acne Vulgaris

United States
Wake Forest University
Medicis Pharmaceutical Corporation

Completed

Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

Acne Vulgaris

United States

3

Subscribe